Abstract The purposes of this paper was to discover whether cirrhosis is a predisposing cause of infectious endocarditis (IE) and to determine the microbiology, prognosis and the role of cardiac surgery on mortality. A review of cases of IE at a university-affiliated hospital over a period of 10 years was conducted. Thirty-one (9.8%) patients among 316 cases of IE had hepatic cirrhosis. Valve disorders were present in 62.2% of cirrhotic patients and infection occurred on the aortic (48%) and mitral valves (45%). Endocarditis was hospital-acquired in 14 (45%) and 11 (17.7%) cirrhotic patients and controls, respectively (odds ratio [OR] 3.82; 95% confidence interval [CI]: 1.46-9.99; p=0.005). Staphylococcus aureus was the most common causative microorganism, but β-hemolytic streptococci were most frequently isolated in cirrhotic patients (OR 8.75; 95% CI: 1.7-45.2; p=0.001). Renal failure was more frequent in patients with cirrhosis (OR 8.23; 95% CI: 3.06-22.2; p=0.001). Cirrhotic patients had a higher mortality (51% vs. 17.7%; OR 4.95; 95% CI: 1.89-12.91; p=0.001) associated with the severity of liver disease. Valve replacement was performed less frequently in cirrhotic patients (56.2% vs. 92%) and the operative mortality was extremely high in patients at stages B and C. Hepatic cirrhosis is a frequent comorbid condition in patients with endocarditis. Due to the presence of severe hepatic dysfunction, cardiac surgery is not undertaken even when indicated and mortality is high in stages B and C. Endocarditis is a serious hazard for hospitalized cirrhotic patients.
Introduction
Patients with cirrhosis of the liver are prone to develop severe bacterial infections due to the presence of various facilitating mechanisms, including changes in the reticuloendothelial system, decreased opsonic activity, leukocyte dysfunction, and iatrogenic factors, among others [1] . Infections such as primary peritonitis, pneumonia, or tuberculosis are acknowledged causes of morbidity and mortality in patients with cirrhosis of the liver, yet, apart from these particular diseases, other infection issues have not been the subject of in-depth investigation [1] .
Infectious endocarditis (IE) occurring in patients with hepatic cirrhosis is rarely reported [2] . Anecdotal case reports of endocarditis associated with invasive procedurestransjugular intrahepatic portosystemic shunt (TIPS), upper endoscopy, sclerotherapy of esophageal varices, or liver biopsy-and caused by unusual pathogens comprise the majority of the articles [3] [4] [5] [6] [7] . However, to the best of our knowledge, studies have not analyzed the impact of liver cirrhosis, a common morbid condition, on the outcome of patients with endocarditis and, thus, some important clinical and prognostic factors of endocarditis in patients with cirrhosis are still poorly known.
The aims of this study were: (i) to discover whether cirrhosis is, in fact, a predisposing cause of IE; (ii) to determine the microbial etiology of IE in this population and other clinically relevant features; and (iii) to assess prognostic factors and how frequently cardiac surgery is needed and performed.
Patients and methods
A retrospective review of consecutive cases of IE in a tertiary university-affiliated hospital that provides service for a population of 350,000 people in downtown Madrid during a period of 10 years (1998-2009) was conducted. A control group composed of two patients per case (the previous and the next to the index case) was used for comparison purposes.
Hepatic cirrhosis was diagnosed by clinical and laboratory criteria and, in some patients, by means of liver biopsy. The severity of liver dysfunction was categorized according to the modified Child-Turcotte-Pugh classification, with a scoring system of 5 to 15: scores of 5 and 6 being class A consistent with compensated cirrhosis; scores of 7 to 9 indicating class B characterized by mild ascitis and minimal encephalopathy; and scores of 10 to 15 class C with poorly controlled ascitis and severe hepatic encephalopathy [8] . The risk of postoperative mortality was assessed by the Model for End-Stage Liver Disease (MELD) [9] with an online tool that used age, type of hepatic disease, the American Society of Anesthesiologists Physical Status Classification (ASA score), and patients' laboratory values for serum bilirubin, serum creatinine, and the International Normalized Ratio for prothrombin time (INR) [10] .
IE was diagnosed by the usual modified Duke's criteria [11] . Only patients with a definite diagnosis of endocarditis were included. Hospital-acquired IE was defined as endocarditis developing ≥72 h after admission in association with a hospital-based procedure or during another hospitalization within the preceding 8 weeks [7] .
Renal failure was defined as an increase in serum creatinine levels ≥1.6 mg/dl persisting ≥24 h, despite the administration of fluids. Central nervous system complications included embolic events and brain hemorrhage, and were evaluated by computed tomography (CT) scanning and magnetic resonance imaging (MRI).
Mortality per episode was calculated. All deaths that occurred during hospitalization as a direct consequence of infection, including operative and perioperative mortality, and any deaths associated with bleeding or acute liver failure occurring during the active phase of infection were considered to be related with endocarditis. Statistics SPSS v11.0 (SPSS Inc., Chicago, IL) was used for the statistical analysis of the data. Continuous variables were expressed as mean (range). Discrete variables were expressed as percentages. Associations were tested by the Chi-square test or the Fisher exact test when samples were small. The strength of associations was measured by the odds ratio (OR) or the Haldane estimator for small-sample 2×2 tables and their 95% confidence interval (CI). Differences in continuous variables were measured by Student's t-test for independent variables. Differences between groups were considered to be significant at p-values <0.05.
Results
Thirty-one (9.8%) patients among 316 cases of IE had cirrhosis of the liver. The mean age of cirrhotic patients was 59.6 years, which was lower than that in the control group. Most patients (71%) were males. The etiology of hepatic disease was alcoholic cirrhosis in 16 patients (51.6%), posthepatitis cirrhosis caused by hepatitis C or B viruses in 11 patients (35.4%), or cryptogenic cirrhosis in four (13%), and were classified as stages A (12), B (8), and C (11) of the Child-Turcotte-Pugh classification. Table 1 shows some relevant epidemiologic and clinical features of endocarditis in patients with cirrhosis of the liver. An underlying predisposing valve disease was present in 62.2% of cirrhotic patients and infection occurred mainly on the aortic (48%) and mitral valves (45%). IE was hospital-acquired in 14 (45%) and 11 (17.7%) of cirrhotic and control patients, respectively (OR 3.82; 95% CI: 1.46-9.99; p=0.005). Central venous catheters (4), urinary tract instrumentation (3), colonoscopy (1), total parenteral nutrition (1), liver biopsy (1), sclerotherapy of esophageal varices (1), and Sengstaken-Blakemore balloon (1) were the recognized sources of bacteremia.
No differences were observed among cirrhotic and control patients in the relative frequency of complications, such as cardiac failure or central nervous system events. However, renal failure was significantly more frequent in patients with cirrhosis of the liver (OR 8.23; 95% CI: 3.06-22.2; p=0.001). Table 2 shows the microbial etiology of IE in patients with cirrhosis of the liver. None of these patients were on chronic, low-dose antimicrobial therapy with fluoroquinolones or other drugs for the prevention of primary bacterial peritonitis. Staphylococcus aureus was the most common causative microorganism in both cirrhotic and control patients. β-hemolytic streptococci, including S. agalactiae and S. pyogenes, were more frequently isolated in patients with cirrhosis of the liver than in controls (OR 8.75; 95% CI: 1.7-45.2; p=0.001). On the other hand, viridans streptococci were uncommonly found in cirrhotic patients (OR 0.1; 95% CI: 0.01-0.83; p=0.002). S. aureus (5), enterococci (4), coagulase-negative staphylococci (2), Escherichia coli (1), Candida albicans (1), and P. aeruginosa (1) were the microorganisms isolated in cirrhotic patients with nosocomial endocarditis.
Sixteen patients (51%) with cirrhosis of the liver and 11 (17.7%) in the control group died during hospitalization for causes associated with endocarditis (OR 4.95; 95% CI: 1.89-12.91; p=0.001). Mortality was associated with the severity of liver disease and, so, while only 2 of 12 (16.6%) patients at stage A died, 6 out of 8 (75%) at stage B and 8 of 11 (72.7%) at stage C died. Cardiac failure, hepatorenal syndrome with acute renal failure, and brain bleeding were the most common causes of death.
Valve replacement was considered in 16 patients with cirrhosis of the liver who developed cardiac failure but was performed in only 9 (56.2%) cases in whom it seemed feasible and indicated. Five of these patients survived (4 at stage A and 1 at stage B) and four died (3 at stage B and 1 at stage C). The calculated postoperative mortality risk of these last patients ranged from 57 to 80% at 30 days and from 69 to 81% at 1 year. In the rest of the cases, valve 
Discussion
Cirrhosis of the liver was a common underlying condition in patients with IE, observed in almost 10% of cases. Cirrhotic patients, particularly those with advanced disease, exhibit leukocyte dysfunction and phagocytic defects that make them prone to develop focal and systemic bacterial infections. The presence of portosystemic shunts and the common occurrence of cutaneous abrasions in edematous legs are potential sources of bacteremia from the gastrointestinal tract and skin. In addition, patients with hepatic cirrhosis are frequently admitted to hospital, where they are the subject of invasive diagnostic and therapeutic procedures, with the potential of producing bacteremia and endocarditis. In this series, endocarditis was a nosocomial infection in 45% of cases, a proportion significantly higher than that found in the control group and much higher than that observed in previous reports on hospital-acquired IE [7, 12] . This observation suggests that IE is a serious hazard for hospitalized patients with cirrhosis of the liver. As shown in previous studies, venous catheters and urinary tract instrumentation were the main sources for bacteremia leading to endocarditis in cirrhotic patients [13] . However, it is interesting to note that other procedures that are commonly undertaken in these patients, such as liver biopsy, or urgent measures for the control of esophageal bleeding, such as sclerotherapy of varices and Sengstaken-Blakemore balloon tamponade, may be associated with bacteremia and endocarditis.
While S. aureus and enterococci were the organisms most frequently found in nosocomial cases, β-hemolytic streptococci were common causes of community-acquired endocarditis in patients with cirrhosis. In previous studies, endocarditis caused by β-hemolytic streptococci has been associated with chronic underlying diseases such as alcoholism and cirrhosis of the liver [14] . Specifically, S. agalactiae that, in the pre-and early antibiotic era was almost exclusively an infection seen in postpartum and postabortal women, is now a microorganism causing severe infections, including bacteremia and endocarditis, in chronically ill patients with cirrhosis of the liver, malignancies, and some other conditions [14, 15] . As noted before, endocarditis caused by S. agalactiae followed a complicated course characterized by large vegetations, the rapid destruction of cardiac valves, and heart failure [15, 16] . In addition, chronic liver disease has been recognized as a predisposing factor for S. bovis bacteremia, which may explain the increased frequency of endocarditis caused by these microorganisms in our series [17] .
Liver cirrhosis has a significant impact on the mortality of patients with bacteremic infections and the high production of proinflammatory cytokines seems to play a role in the worsening of liver function and the development of organ system failures, such as hepato-renal syndrome or hepatic encephalopathy [18, 19] . Remarkably, renal failure occurred in most of our cases and seemed to contribute to the poor outcome of patients. Besides heart failure, acute renal failure was a major determinant of mortality.
The mortality of cardiac surgery of patients with advanced liver cirrhosis is extremely high [20] and, so, the decision to operate on these patients is difficult. In this series, although indicated in most patients with cardiac failure, valve replacement was precluded in many due to the presence of end-stage liver disease and, when performed, only patients in good functional state survived. The MELD score, which has been recently validated to quantify the risk of mortality postoperatively in patients with cirrhosis, may be a useful tool in the task of deciding whether or not these patients must been sent to the operating room for valve replacement [21] .
In summary, we show herein data which suggest that IE in patients with cirrhosis of the liver is a severe disease with unique community-acquired etiologic agents. Besides, IE is frequently acquired during hospitalization as a consequence of invasive diagnostic or therapeutic procedures. When indicated, valve replacement can be successfully performed in patients with minor or mild hepatic dysfunction. However, the operative mortality of patients at Child stages B and C is extremely high and should probably be undertaken only in selected individuals with cardiac failure without renal failure and other systemic complications.
Finally, because most of the factors facilitating the development of bacterial infections in cirrhotic patients are unchangeable and many cases occur during hospitalization, prevention should focus on measures to avoid bacteremia and other nosocomial infections. New studies are required to better determine the role of cardiac surgery in the management of IE in cirrhotic patients.
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